Price
394.25
+1.62%52W Range
Market Cap
₹470.46 Cr
Traded: ₹0.79 Cr (0.17%) 0.0x
Free Float: ₹125.19 Cr (0.63% of FF traded)
Volume · 60D trend
19.8 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | +60.0% | -- | +48.0% | Decelerating |
| ROE | -- | +21.0% | +20.0% | -- | -- | Decelerating |
| Return | -- | -- | +20.0% | -15.0% | -- | Decelerating |
| Profit | -- | -- | +47.0% | -- | +62.0% | Accelerating |
Quarterly Results
Dec 2022
Jun 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022PDF ↗ | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 50 | 26 | 31 | 24 | 34 | 12 | 15 | 13 | 19 | 7 | 19 | 9 | 8 | 9 | 14 | 6 |
| Expenses | 25 | 39 | 21 | 24 | 18 | 25 | 8 | 11 | 11 | 17 | 6 | 15 | 7 | 7 | 7 | 12 | 5 |
| Operating Profit | 9 | 11 | 5 | 7 | 5 | 9 | 4 | 4 | 2 | 2 | 1 | 4 | 2 | 2 | 2 | 2 | 1 |
| Other Income | 1 | 2 | 5 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 2 | 1 | 1 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 11 | 6 | 7 | 4 | 6 | 3 | 4 | 3 | 3 | 1 | 4 | 2 | 2 | 2 | 2 | 1 |
| Tax % | 23.3% | 36.0% | 22.8% | 23.2% | 29.3% | -0.3% | 26.5% | 28.5% | 38.7% | 46.9% | 21.6% | 25.0% | 24.7% | 14.3% | 4.7% | 6.0% | 0.0% |
| Net Profit | 5 | 7 | 5 | 5 | 3 | 6 | 3 | 3 | 2 | 2 | 1 | 3 | 1 | 2 | 2 | 2 | 1 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 4.2 | 5.6 | 3.6 | 4.3 | 2.7 | 6.2 | 2.4 | 2.7 | 2.0 | 1.8 | 0.9 | 2.7 | 1.2 | 1.7 | 1.8 | 2.5 | 0.9 |
| Sales Growth (YoY) | -- | 52.0% | 117.0% | 103.0% | 80.0% | 78.0% | 67.0% | -- | 52.0% | 126.0% | -25.0% | 35.7% | 45.0% | -5.0% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 195.6% | -51.5% | 124.5% | -52.8% | 322.6% | -59.2% | 120.5% | -49.4% | 266.7% | -62.7% | 119.9% | -52.0% | 91.3% | -32.8% | 134.5% | -- |
| OP Growth (YoY) | 64.8% | 28.7% | 25.1% | 69.4% | 107.6% | 261.9% | 184.6% | 1.2% | 41.5% | 21.6% | -27.8% | 100.0% | 104.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -22.5% | 115.9% | -25.8% | 32.7% | -39.5% | 109.8% | 0.5% | 62.7% | 5.5% | 65.0% | -64.3% | 127.3% | -9.3% | -2.0% | -1.0% | 132.6% | -- |
| Profit Growth (YoY) | -- | -- | 54.0% | 60.0% | 34.0% | 248.0% | 158.0% | -- | 64.0% | 3.0% | -47.0% | -- | 100.0% | -29.0% | -- | -- | -- |
| EPS Growth (YoY) | -- | 46.4% | 48.1% | 47.3% | 33.7% | 156.5% | 158.5% | 73.7% | 63.1% | -29.1% | -46.6% | 7.1% | 38.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 156.7% | -47.9% | 159.8% | -57.8% | 159.7% | -48.2% | 135.7% | -19.1% | 161.7% | -65.2% | 121.3% | -64.8% | 97.2% | -30.2% | 186.4% | -- |
| OP Margin | -- | 21.1% | 19.8% | 22.6% | 21.9% | 18.0% | 34.4% | 24.1% | 18.9% | 15.4% | 20.2% | 21.1% | 20.4% | 22.2% | 21.0% | 14.3% | 14.4% |
| Net Margin | -- | 14.5% | 18.1% | 15.1% | 11.8% | 12.0% | 21.6% | 13.8% | 12.2% | 11.5% | 14.8% | 15.8% | 16.2% | 22.2% | 21.5% | 14.3% | 11.7% |
| Material Cost % | -- | 64.0% | 59.0% | 53.0% | 46.0% | 56.0% | 31.0% | 54.0% | 58.0% | 69.0% | 59.0% | 62.0% | 63.0% | 62.0% | 66.0% | 66.0% | 65.0% |
| Employee Cost % | -- | 6.0% | 10.0% | 11.0% | 11.0% | 11.0% | 11.0% | 8.0% | 8.0% | 5.0% | 7.0% | 5.0% | 6.0% | 5.0% | 4.0% | 5.0% | 5.0% |
| P/S | 3.34 | 1.78 | 2.53 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 22.24 | 11.85 | 14.57 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.70 | 3.17 | 2.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Allotment of 24000 Equity Shares pursuant to conversion of warrants.
Allotment of 24000 Equity Shares Pursuant to conversion of Warrants.
Please find attached herewith copies of the newspaper advertisements published in Financial Express (English) and Financial Express (Gujarati) regarding the corrigendum to the Notice of ....
Trident Lifeline Limited has issued corrigendum to the Notice of EOGM
Outcome of Board Meeting held on 16.10.2026
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....
Please find enclosed Press Release titled 'CPHI Milan 2026: Opening doors to regulated markets and new global business opportunities' issued on October 09, 2026.
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from MUFG Intime India Private Limited (Formally ....
Please find attached herewith copies of newspaper advertisements published in the Financial Express (English) and Financial Express (Gujarati), regarding notice of Extra Ordinary General ....
This is in continuation of the Outcome of the Board Meeting submitted by the Company to the Exchange on October 05, 2026 regarding the Board Meeting held on October 5, 2026 pursuant to ....
We would like to inform you that the Extra-Ordinary General Meeting is scheduled to be held on Tuesday, October 27, 2026, at 04.00 p.m.(IST) through Video Conferencing ("VC") or Other Audio ....
The Board of Director has approved the alteration of Article of Association, subject to the approval of Members
Trident Lifeline Limited has announced the issue of Equity shares and Warrants on preferential basis.
Outcome of Board Meeting held on 05.10.2026
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company ....
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Analysts/Investors ....
With reference to our letter dated September 29, 2026 and Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, we wish to inform you that the Trading Window for dealing in ....
We wish to inform to the Exchange that Trident Lifeline Limited has made further Investment by acquiring an additional equity stake of 1.00% of TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), ....
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2026 ,inter alia, to consider and approve 1. the proposal to raise funds, ....
The Exchange has sought clarification from Trident Lifeline Ltd on September 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure requirements) Regulation, 2015, ('the Listing Regulations'), we wish to inform ....
With reference to the above-captioned subject, we are pleased to inform you that Trident Lifeline Limited has been honoured by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) ....
Please find attached herewith copies of newspaper advertisements published in the Financial Express (English) and Financial Express (Gujarati), regarding notice of 13th Annual General Meeting ....
Annual Report for FY 2025-26
The 13th Annual General Meeting ("AGM") of the Company will be held on Saturday, September 26, 2026 at 04:00 p.m. IST through Video Conferencing / Other Audio-Visual Means
The Book Closure period and Cut-off date for remote e-voting and e-voting during the AGM shall stand revised as under: Book Closure: Sunday, September 20, 2026 to Saturday, September ....
Pursuant to Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on September 01, 2026 in accordance with latest Circular No. 03/2025 ....
Allotment of 24000 Shares upon convserion of Warrants into Equity
Allotment of 24000 Equity Shares of Rs. 10/- each upon conversion/ exchange of equal number of warrants
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has been selected to receive a prestigious ....
Outcome of Board Meeting held on 26.08.2026
Outcome of Board Meeting held on 26.08.2026
13th Annual General Meeting ('AGM') of the Members of Trident Lifeline Limited scheduled to be held on Saturday, September 26, 2026 at 04:00 p.m. through Video Conferencing ('VC')/Other ....
Pursuant to section 91 of Companies Act, 2013 and Regulation 42 of SEBI (LODR) Regulation, 2015, the Register of Members and Share Transfer books of the Company will remain closed from ....
Announcement under Regulation 30 (LODR)-Trident Lifeline Limited featured in India Pharma Outlook Magazine
With reference to the above-captioned subject, we are pleased to inform you that the Company has been honoured with the prestigious award under the category 'Fastest Growing SMEs' at the ....
Outcome of Analyst/Institutional Investor Meeting
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the company is selected for a prestigious award under category ....
Pursuant to the requirements of Regulation 30 of the Securities Exchange Board of India (Listing obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that ....
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
With reference to captioned subject, we are enlcosing herewith voting Result along with Scrutinzer Report. Please take the same on your records.
With reference to captioned subject, we are enclosing herewith Voting Result and scrutinizer Report. Please take the same on your records.
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from MUFG Intime India Private Limited (Formally ....
Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....
With Refrence to Captioned Subject, please find enlcosed herewith newspaper advertisement published in Financial Express (English & Gujarati) on June 15, 2026 for the postal ballot of the Company.
With refrecne to captioned subject, please find enlsed herewith potsl ballot notice.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust